Medulloblastoma non-WNT/non-SHH group 4
MONDO:0956967A medulloblastoma non-WNT/non-SHH that is characterized as a molecular subtype by the absence of MYC amplifications and TP53 mutations, while chromosome 17 abnormalities may be present.
1508 clinical trials for this condition and its sub-types, 2 tagged with Medulloblastoma non-WNT/non-SHH group 4 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Immune cocktail takes on tough brain cancer in kids
Disease control Recruiting nowThis early-phase trial is testing whether a combination of immune-based treatments is safe and feasible for children and young adults (ages 4–30) with a recurrent form of medulloblastoma, a type of brain cancer. The treatment includes personalized dendritic cell vaccines, immune …
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for toddlers with aggressive brain cancer: experimental spinal-fluid chemo
Disease control Recruiting nowThis early-phase study tests whether adding chemotherapy directly into the spinal fluid (intrathecal topotecan) followed by maintenance pills is feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will receive this treatment after standard high-…
Early phase 1 • Sponsor: C17 Council • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC